"Parasympatholytics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.
Descriptor ID |
D010276
|
MeSH Number(s) |
D27.505.696.663.050.650
|
Concept/Terms |
Parasympatholytics- Parasympatholytics
- Parasympatholytic Drugs
- Drugs, Parasympatholytic
- Parasympathetic-Blocking Agents
- Agents, Parasympathetic-Blocking
- Parasympathetic Blocking Agents
- Parasympatholytic Agents
- Agents, Parasympatholytic
Parasympatholytic Effect- Parasympatholytic Effect
- Effect, Parasympatholytic
- Parasympatholytic Effects
- Effects, Parasympatholytic
Antispasmodic Effect- Antispasmodic Effect
- Effect, Antispasmodic
- Antispasmodic Effects
- Effects, Antispasmodic
Antispasmodics- Antispasmodics
- Antispasmodic Drugs
- Drugs, Antispasmodic
- Spasmolytics
- Antispasmodic Agents
- Agents, Antispasmodic
|
Below are MeSH descriptors whose meaning is more general than "Parasympatholytics".
Below are MeSH descriptors whose meaning is more specific than "Parasympatholytics".
This graph shows the total number of publications written about "Parasympatholytics" by people in this website by year, and whether "Parasympatholytics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 4 | 0 | 4 |
2018 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Parasympatholytics" by people in Profiles.
-
Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later. J Pain Symptom Manage. 2018 12; 56(6):902-907.
-
Pycnogenol® supplementation improves the control of irritable bowel syndrome symptoms. Panminerva Med. 2018 Jun; 60(2):65-69.
-
[Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy]. Epidemiol Prev. 2017 Sep-Dec; 41(5-6):279-293.
-
Transcutaneous posterior tibial nerve electrostimulation with low dose trospium chloride: Could it be used as a second line treatment of overactive bladder in females. Neurourol Urodyn. 2018 02; 37(2):842-848.
-
Rome foundation Asian working team report: Real world treatment experience of Asian patients with functional bowel disorders. J Gastroenterol Hepatol. 2017 Aug; 32(8):1450-1456.
-
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study). PLoS One. 2017; 12(8):e0180651.